Publication | Open Access
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial
21
Citations
7
References
2024
Year
UrologyGenitourinary CancerMedicinePharmacologyClinical TrialsPharmacotherapyCancer TreatmentPhase 2Primary Endpoint ResultsOncologyProstatic DiseaseTumor-directed Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1